Correction: In the Clinic: Migraine. Ann Intern Med. 2008;148:408. doi: 10.7326/0003-4819-148-5-200803040-00024
Download citation file:
Published: Ann Intern Med. 2008;148(5):408.
In the recent In the Clinic issue on Migraine (1), Table 4 contained an error. The mechanism of action for amitriptyline should say “Inhibits norepinephrine”; the side effects for methysergide should say “No longer available in the United States.” Text at the bottom of the page should say, “Valproate and topiramate are the only anticonvulsants approved by the U.S. Food and Drug Administration for migraine prevention.”
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only